Altimmune

Altimmune is a clinical-stage biopharmaceutical company focused on developing treatments for obesity and liver diseases as well as intranasal vaccines. Our pipeline includes next-generation peptide therapies for obesity, NASH (ALT-801), and chronic hepatitis B (HepTcell™); proprietary intranasal vaccines; and an immunomodulatory therapy for COVID-19 (T-COVID™).